National Research Corporation (NASDAQ:NRC) Q2 2022 Earnings Conference Call August 3, 2022 11:00 AM ET

Company Participants

Michael Hays - Founder and Chief Executive Officer

Kevin Karas - Chief Financial Officer

Conference Call Participants

John Lewis - Willis Investment Counsel

George D'Angelo - Alpine Peaks Capital

Operator

Hello, everyone, and welcome to the National Research Corporation’s Second Quarter 2022 Earnings Call. My name is Charlie and I'll be coordinating the call today. You will have the opportunity to ask your questions at the end of the presentation. [Operator Instructions]

I will hand over to your host, Mike Hays, CEO to begin. Mike, please go ahead.

Michael Hays

Thank you, Charlie and welcome everyone to National Research Corporation's second quarter earnings call. My name is Mike Hays, the company's CEO, and joining me on the call today is Kevin Karas, our Chief Financial Officer.

Before we continue, I would ask Kevin to review conditions related to any forward-looking statements that may be made as part of today's call. Kevin?

Kevin Karas

Thank you, Mike. This conference call includes forward-looking statements related to the company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the company's future results, please see the company's filings with the Securities and Exchange Commission.

With that, I'll turn it back to you, Mike.

Michael Hays

Thank you, Kevin. And again, welcome, everyone. The clear headline for the quarter is that Novant health, which is an integrated healthcare system, serving four states with 15 medical centers and 600 clinics, has contracted for our Human Understanding Program, being the first health system in the country able to deliver personalized care at scale.

Novant Health's adoption of the program enables care teams to understand each patient's fear and expectations and have that information accessible for their use at each interaction so that each patient is treated as a unique person.

Let me now turn the call back to Kevin to review our financial performance and then open the call to your questions.

Kevin Karas

Thank you, Mike. Our growth strategy continues to focus on organic levers of increasing revenue from core offerings, including our new human understanding program, both within our existing client base, as well as adding new clients increased market share.